NCT00005617
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,773 public trials
496 recruiting studies
Neuroendocrine Tumors trial results
Completed
Nintedanib(BIBF1120) in Thyroid Cancer
NCT01788982
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- A.Z. St. Jan Bruges, Belgium
- Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- Universitair Ziekenhuis Antwerpen Edegem, Antwerpen, Belgium
NCT00498979
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +25 more
- Locations
-
- Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01656642
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- UCLA Los Angeles, California, United States
- The Angeles Clinic and Research Institute - W LA Office Los Angeles, California, United States
- University of Colorado Health Science Center; Biomedical Research Bldg. Room 511 Aurora, Colorado, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
NCT03253666
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +25 more
- Locations
-
Not specified
NCT03415126
- Conditions
- Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +51 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
- South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
Completed
Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
NCT01211262
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- The Angeles Clinic Los Angeles, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Memorial Slone Kettering Cancer Center New York, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT02823405
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Clinical Site Atlanta, Georgia, United States
- Clinical Site Iowa City, Iowa, United States
- Clinical Site Houston, Texas, United States
- Clinical Site Salt Lake City, Utah, United States
NCT01773655
- Conditions
- Adenocarcinoma, Adenoma, Carcinoma, +40 more
- Locations
-
- Memorial Sloan Kettering Westchester Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Family Study of Melanoma in Italy
NCT00339222
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevi, Dysplastic Nevus Syndrome, +17 more
- Locations
-
- Ospedale Maurizio Bufalini Cesena, Italy Cessana, Italy
- University of Genoa Genoa, Italy
- University of L'Aquila L’Aquila, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy